Cardiac resynchronization therapy for heart failure management

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• Heart failure (HF) presents a significant healthcare burden, with increasing prevalence due to aging populations and improved acute coronary syndrome treatments.
• Despite pharmacotherapies like ACE inhibitors and beta-blockers, HF patient prognosis remains poor, and cardiac transplantation is limited.
• Conduction disturbances and ventricular dyssynchrony frequently complicate advanced HF, worsening systolic function.

Purpose of the Study:

• To provide an overview of cardiac resynchronization therapy (CRT).
• To describe ventricular dyssynchrony in heart failure patients.
• To outline the benefits of CRT and its implications for advanced practice nurses.

Main Methods:

• Review of randomized clinical trials on biventricular pacing for HF.
• Analysis of data on the efficacy of cardiac resynchronization therapy (CRT).
• Discussion of combined biventricular pacing and implantable cardioverter defibrillator therapy.

Main Results:

• Cardiac resynchronization therapy (CRT) through biventricular pacing offers significant benefits in morbidity and mortality for a select group of HF patients with intraventricular conduction defects.
• Ventricular dyssynchrony is a frequent complication in advanced HF, impacting systolic function.
• Combined biventricular pacing and implantable cardioverter defibrillator therapy may provide additional benefits in reducing sudden cardiac death.

Conclusions:

• Cardiac resynchronization therapy (CRT) is a promising treatment for select heart failure patients experiencing ventricular dyssynchrony.
• The integration of CRT with implantable cardioverter defibrillator therapy warrants consideration for patients with severe HF.
• Understanding CRT is crucial for advanced practice nurses managing heart failure patients.